Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.060
+0.020 (0.98%)
Jun 5, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 384.1 million as of June 5, 2026. Its market cap has decreased by -32.67% in one year.
Market Cap
384.10M
Enterprise Value
676.54M
Revenue
737.49M
Ranking
n/a
PE Ratio
14.61
Stock Price
2.06
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 384.10M, a decrease of -44.36%. That is a compound annual growth rate of -10.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 384.10M | -26.83% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.56B |
| Integral Diagnostics | 771.05M |
| Monash IVF Group | 270.80M |
| Healius | 235.99M |
| Cryosite | 51.74M |
| INOVIQ | 47.86M |
| Microba Life Sciences | 38.36M |
| Rhythm Biosciences | 37.16M |